Value investing message boards image Log on |  Join ($$) Stock market forums image VF "How To" Guide        Welcome, guest! Learn about guest access                       
ValueForum.com Home
• Related Discussion Forum Messages
As a ValueForum member, this section would contain XENT message board posts where the ticker symbol XENT has been mentioned by ValueForum members in posts. Learn more about guest access, and benefits of membership -- we hope you will consider joining ValueForum or trying out our service with a 24 hour trial pass.

• Latest XENT SEC Filings

Filings Format Description Filing Date File/Film Number
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001562180-18-003331 Size: 10 KB
2018-07-18
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001562180-18-003282 Size: 9 KB
2018-07-12
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001562180-18-003060 Size: 10 KB
2018-06-19
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001562180-18-002921 Size: 9 KB
2018-06-07
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001562180-18-002920 Size: 7 KB
2018-06-07
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001562180-18-002919 Size: 7 KB
2018-06-07
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001562180-18-002918 Size: 10 KB
2018-06-07
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001562180-18-002917 Size: 7 KB
2018-06-07
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001562180-18-002916 Size: 7 KB
2018-06-07
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001562180-18-002915 Size: 7 KB
2018-06-07
More XENT SEC Filings


Related news from
Tue, 17 Jul 2018
20:06:02 +0000
Minerva Neurosciences Elects Jeryl Hilleman to Board of Directors
WALTHAM, Mass., July 17, 2018 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous ...
Wed, 11 Jul 2018
21:19:00 +0000
Intersect ENT to Report Second Quarter 2018 Financial Results
Intersect ENT, Inc. (XENT), a company seeking to improve the quality of life for patients with ear, nose and throat conditions, today announced that it will release financial results for its second quarter on August 1, 2018. The company expects to issue the release at approximately 4 p.m. ET and management will host a conference call at 4:30 p.m. ET. To access the conference call via the internet, go to the "Investor Relations" page of the company's website at www.intersectENT.com.
Mon, 18 Jun 2018
16:11:00 +0000
Faruqi & Faruqi, LLP is Investigating Intersect ENT, Inc. (XENT) on Behalf of its Shareholders
NEW YORK , June 18, 2018 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential breaches of fiduciary duty by the board of directors at Intersect ENT, ...
Fri, 01 Jun 2018
12:44:00 +0000
3 Top Healthcare Stocks to Buy Right Now
Here's why these healthcare specialists believe it's a great time to buy a few shares of these three healthcare winners.
Tue, 29 May 2018
20:05:00 +0000
Intersect ENT to Present at William Blair & Company 38th Annual Growth Stock Conference
Intersect ENT, Inc. today announced that management will present at the 38th Annual William Blair Growth Stock Conference.
Sun, 06 May 2018
16:02:28 +0000
Best NasdaqGM Growth Companies
Looking to enhance your portfolio with high-growth, financially-robust stocks, but not sure where you should even begin? Stocks such as AcelRx Pharmaceuticals and Intersect ENT are deemed to be superiorRead More...
Sat, 05 May 2018
11:51:59 +0000
Edited Transcript of XENT earnings conference call or presentation 1-May-18 8:30pm GMT
Q1 2018 Intersect ENT Inc Earnings Call
Tue, 01 May 2018
20:05:00 +0000
Intersect ENT Reports First Quarter 2018 Results
Intersect ENT, Inc. , a company dedicated to improving the quality of life for patients with ear, nose and throat conditions, today reported financial results for the first quarter ended March 31, 2018.
Tue, 24 Apr 2018
07:53:10 +0000
Investor Expectations to Drive Momentum within AMN Healthcare Services, Cass Information, William Lyon Homes, AMAG Pharmaceuticals, Intersect ENT, and First Financial — Discovering Underlying Factors of Influence
NEW YORK, April 24, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ...
Tue, 17 Apr 2018
20:05:00 +0000
Intersect ENT to Present at Deutsche Bank and Bank of America Merrill Lynch Conferences
Intersect ENT, Inc. today announced that management will present at Deutsche Bank’s 43rd Annual Health Care Conference and at Bank of America Merrill Lynch 2018 Healthcare Conference.
Mon, 16 Apr 2018
20:19:00 +0000
Intersect ENT to Report First Quarter 2018 Financial Results
Intersect ENT, Inc. , a company seeking to improve the quality of life for patients with ear, nose and throat conditions, today announced that it will release financial results for its first quarter on May 1, 2018.
Mon, 02 Apr 2018
12:00:00 +0000
Intersect ENT Announces Launch of SINUVA™ Sinus Implant, a New In-Office Treatment Option for Recurrent Nasal Polyps
Intersect ENT, Inc. , a company dedicated to transforming care for patients with ear, nose and throat conditions, today announced U.S. commercial availability of the SINUVA™ Sinus Implant, a new approach to treating nasal polyp disease in adult patients who have had previous sinus surgery.
Thu, 01 Mar 2018
04:48:06 +0000
Intersect ENT Inc (XENT) Files 10-K for the Fiscal Year Ended on December 31, 2017
Intersect ENT Inc (NASDAQ:XENT) files its latest 10-K with SEC for the fiscal year ended on December 31, 2017.
Wed, 28 Feb 2018
19:11:17 +0000
Edited Transcript of XENT earnings conference call or presentation 27-Feb-18 9:30pm GMT
Q4 2017 Intersect ENT Inc Earnings Call
Tue, 27 Feb 2018
21:05:00 +0000
Intersect ENT Reports Fourth Quarter and Full Year 2017 Results
Intersect ENT, Inc. , a company dedicated to improving the quality of life for patients with ear, nose and throat conditions, today reported financial results for the fourth quarter and year ended December 31, 2017.
Tue, 27 Feb 2018
17:50:00 +0000
Intersect ENT Inc to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / February 27, 2018 / Intersect ENT Inc (NASDAQ: XENT ) will be discussing their earnings results in their Q4 Earnings Call to be held on February 27, 2018 at 4:30 PM Eastern ...
Tue, 27 Feb 2018
11:07:19 +0000
Intersect ENT Inc’s (NASDAQ:XENT) Path To Profitability
Intersect ENT Inc’s (NASDAQ:XENT): Intersect ENT, Inc., a commercial stage drug-device company, provides therapeutic solutions for patients with ear, nose, and throat conditions in the United States. The US$1.06B market-capRead More...
Thu, 08 Feb 2018
21:05:00 +0000
Intersect ENT to Report Fourth Quarter and Year 2017 Financial Results
Intersect ENT, Inc. , a company seeking to improve the quality of life for patients with ear, nose and throat conditions, today announced that it will release financial results for its fourth quarter and year 2017 on February 27, 2018.



"ValueForum is an active, private, online discussion community for stock & bond market investing. In discussion forums divided into finely grained topics, you will find sophisticated investors trading tips, research, and due diligence on value stocks, income investments, forex, market news, and more. Join in - trade ideas, strategies, current news, via our unique message bulletin boards, stock ratings system, and other online tools specifically geared toward our community."

Random member testimonial: "VF is the place to be to pick up on new and proven investment ideas." more testimonials »

Email / About | Privacy | Terms of Use | How To / FAQ | Msg Ticker | VF Home | My.vf | BDCs.vf | Energy.vf | REITs.vf | TA.vf
 
Nothing in ValueForum.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by ValueForum.com. ©2003 - 2018, Powered in part by Ticker TechnologiesContact Us

Stock Market Investing Forum - Trading Tips & Research - Online Message Boards